45 related articles for article (PubMed ID: 10379126)
1. Recurrence of endometrial cancer in a hysterectomised patient treated with tamoxifen for breast cancer: a case report.
Woolas J; Davis M; Rahimi S
J R Soc Med; 2020 Nov; 113(11):454-456. PubMed ID: 33044110
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and therapeutic challenges in a recurrent endometrial carcinoma in lung, 15 years after primary treatment.
Upadhyay AK; Kumar M; Prakash A; Kumar A
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38782427
[TBL] [Abstract][Full Text] [Related]
3. Survival from ovarian and endometrial cancer.
Chien P
BJOG; 2023 Dec; 130(13):1561-1562. PubMed ID: 37919043
[No Abstract] [Full Text] [Related]
4. Endometrial metastasis from breast cancer in a patient receiving tamoxifen therapy.
Horn LC; Einenkel J; Baier D
Gynecol Obstet Invest; 2000; 50(2):136-8. PubMed ID: 10965200
[TBL] [Abstract][Full Text] [Related]
5. Benign, borderline, and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy.
McCluggage WG; Bryson C; Lamki H; Boyle DD
Int J Gynecol Pathol; 2000 Jul; 19(3):276-9. PubMed ID: 10907178
[TBL] [Abstract][Full Text] [Related]
6. Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy.
Hoff PM; Valero V; Buzdar AU; Singletary SE; Theriault RL; Booser D; Asmar L; Frye D; McNeese MD; Hortobagyi GN
Cancer; 2000 May; 88(9):2054-60. PubMed ID: 10813717
[TBL] [Abstract][Full Text] [Related]
7. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.
Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE
Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892
[TBL] [Abstract][Full Text] [Related]
8. A case of simultaneous presence of primary endometrial carcinoma and metastasis of a breast carcinoma to the ovary after 5 years of tamoxifen therapy.
Ishioka S; Sagae S; Kobayashi K; Sugimura M; Nishioka Y; Kudo R
J Obstet Gynaecol Res; 1999 Apr; 25(2):113-7. PubMed ID: 10379126
[TBL] [Abstract][Full Text] [Related]
9. Controversies regarding tamoxifen and uterine carcinoma.
Neven P; Vergote I
Curr Opin Obstet Gynecol; 1998 Feb; 10(1):9-14. PubMed ID: 9484623
[TBL] [Abstract][Full Text] [Related]
10. Primary ovarian small cell carcinoma of pulmonary type with coexisting endometrial carcinoma in a breast cancer patient receiving tamoxifen: A case report and literature review.
Yin L; Li J; Wei Y; Ma D; Sun Y; Sun Y
Medicine (Baltimore); 2018 Jun; 97(23):e10900. PubMed ID: 29879027
[TBL] [Abstract][Full Text] [Related]
11. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
